Yoga for Depression
Trial Summary
What is the purpose of this trial?
The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.
Will I have to stop taking my current medications?
If you are currently using antidepressant medication, you cannot participate in this trial. The trial is for those not taking antidepressants.
What data supports the effectiveness of the treatment Yoga, Mindfulness Program, Meditation Program, Yoga Therapy for depression?
Is yoga generally safe for humans?
How is yoga different from other treatments for depression?
Research Team
Sudha Prathikanti, MD
Principal Investigator
University of California, San Francisco
Eligibility Criteria
Adults over 18 with mild-to-moderate major depression can join this study in San Francisco. Participants must speak English well and be able to attend all sessions. They shouldn't have severe mental illnesses besides depression, use antidepressants or psychotherapy during the trial, or have certain medical conditions like severe pulmonary disease.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to one of three in-person group interventions: Standard yoga practice, Ayurvedic yoga practice, or educational attention-control modules for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Yoga
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor